Anti-SARS-CoV-2 Agents in

Artemisia SARS-CoV-2 antivirus endophytic abundance endophytic fungi metabarcoding

Journal

Journal of fungi (Basel, Switzerland)
ISSN: 2309-608X
Titre abrégé: J Fungi (Basel)
Pays: Switzerland
ID NLM: 101671827

Informations de publication

Date de publication:
05 Sep 2023
Historique:
received: 04 08 2023
revised: 30 08 2023
accepted: 31 08 2023
medline: 27 9 2023
pubmed: 27 9 2023
entrez: 27 9 2023
Statut: epublish

Résumé

Coronavirus disease 2019 is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Therapeutic agents for the disease are being developed. Endophytes are diverse and produce various secondary metabolites and bioactive substances. We isolated 13 endophytes from the leaves and stems of

Identifiants

pubmed: 37755013
pii: jof9090905
doi: 10.3390/jof9090905
pmc: PMC10532694
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Japan Science and Technology Agency
ID : JPMJSC15H1
Organisme : Japan Society for the Promotion of Science
ID : 23K06189

Références

Microorganisms. 2021 Jan 21;9(2):
pubmed: 33494367
Science. 1993 Apr 9;260(5105):214-6
pubmed: 8097061
Nat Methods. 2016 Jul;13(7):581-3
pubmed: 27214047
Arch Pharm Res. 2019 Sep;42(9):735-753
pubmed: 30915681
J Nat Prod. 2009 Jan;72(1):2-7
pubmed: 19119919
Microorganisms. 2020 Sep 04;8(9):
pubmed: 32899776
J Ethnopharmacol. 2021 Jun 28;274:114016
pubmed: 33716085
New Phytol. 2005 Jun;166(3):1063-8
pubmed: 15869663
Trends Plant Sci. 2004 Jun;9(6):275-80
pubmed: 15165558
J Nat Prod. 2008 Feb;71(2):159-62
pubmed: 18220354
J Fungi (Basel). 2018 May 01;4(2):
pubmed: 29724011
Nat Biotechnol. 2019 Aug;37(8):852-857
pubmed: 31341288
Appl Microbiol Biotechnol. 2015 Apr;99(7):2955-65
pubmed: 25750045
J Nat Med. 2023 Sep;77(4):916-927
pubmed: 37247107
J Nat Med. 2013 Apr;67(2):421-3
pubmed: 22886817
J Nat Prod. 2006 Aug;69(8):1121-4
pubmed: 16933860
Viruses. 2023 Feb 06;15(2):
pubmed: 36851666
Cell. 2018 Nov 1;175(4):973-983.e14
pubmed: 30388454

Auteurs

Shoji Maehara (S)

Faculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University, Sanzo,1 Gakuen-cho, Fukuyama, Hiroshima 729-0292, Japan.

Shogo Nakajima (S)

Department of Virology II, National Institute of Infectious Diseases, Toyama 1-23-1, Shinjuku-ku, Tokyo 162-8640, Japan.
Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Toyama 1-23-1, Shinjuku-ku, Tokyo 162-8640, Japan.

Koichi Watashi (K)

Department of Virology II, National Institute of Infectious Diseases, Toyama 1-23-1, Shinjuku-ku, Tokyo 162-8640, Japan.
Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Toyama 1-23-1, Shinjuku-ku, Tokyo 162-8640, Japan.

Andria Agusta (A)

Research Center for Pharmaceutical Ingredients and Traditional Medicine, National Research and Innovation Agency (BRIN), Jalan Raya Bogor Km 46, Cibinong, Bogor 16911, Indonesia.
Medical Faculty, Malahayati University, Jl. Pramuka No.27, Kemiling Permai, Bandar Lampung 35152, Indonesia.

Misato Kikuchi (M)

Faculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University, Sanzo,1 Gakuen-cho, Fukuyama, Hiroshima 729-0292, Japan.

Toshiyuki Hata (T)

Faculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University, Sanzo,1 Gakuen-cho, Fukuyama, Hiroshima 729-0292, Japan.

Kento Takayama (K)

Faculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University, Sanzo,1 Gakuen-cho, Fukuyama, Hiroshima 729-0292, Japan.

Classifications MeSH